The Walter and Eliza Hall Institute of Medical Research’s $250 Million monetization of a portion of its royalties relating to the cancer drug Venetoclax

Covington advised The Walter and Eliza Hall Institute of Medical Research (WEHI), Australia’s oldest medical research institute, in its landmark monetization of a portion of its…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here